Treatment Resistant Depression Market Investigation: Market Size, Future Prospects, and Competitive Analysis, through 2025

Published By: Brisk Insights | Published On: May 7, 2017

Brisk Insights has published a study titled “Treatment Resistant Depression Market Investigation: Market Size, Future Prospects, and Competitive Analysis, through 2025″, involves the global markets for Treatment Resistant Depression by segments, regional classification, profiling of major market players and competitive front for the period 2017 to 2025.

 

Our report on Treatment Resistant Depression market provides in-depth analysis covering key market trends, market dynamics, and market size of the Treatment Resistant Depression industry. The factors considered during the course of research are product/service definition, product/service classification, industry structure, participants in the value chain, etc. Highlights of the report are market size and forecast for the period 2015 to 2025, and compounded annual growth rate derived for each segment and regional distribution, competitive analysis of key market players, assessment of market dynamics and profiling of key companies engaged in the Treatment Resistant Depression market.

 

Report Scope: Treatment Resistant Depression Market

This report provides a comprehensive assessment of the Treatment Resistant Depression market presented through sections such as:

  1. Treatment Resistant Depression: Market Overview
  2. Major Commercial Developments in the Treatment Resistant Depression Industry
  3. Market Dynamics of Treatment Resistant Depression Industry
  4. Vendor Landscape of Treatment Resistant Depression Industry
  5. Porter’s Five Forces Model of Treatment Resistant Depression Industry
  6. PESTEL Analysis of Treatment Resistant Depression Industry
  7. Market Positioning of Key Market Players in Treatment Resistant Depression Industry
  8. Major Market Trends and Future Prospects of the Treatment Resistant Depression Market
  9. Competitive Assessment of the Treatment Resistant Depression Market
  10. Treatment Resistant Depression Market, Size and Forecast, by Key Segments, 2015 to 2025
  11. Treatment Resistant Depression Market, Size and Forecast, by Geography, 2015 to 2025

Geographic Distribution:

1.North America Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

a.U.S. Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

b.Canada Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

2.Europe

a.U.K. Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

b.Germany Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

c.France Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

d.Rest of Europe Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

3.Asia-Pacific Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

a.China Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

b.Japan Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

c.India Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

d.Rest of Asia-Pacific Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

4.Rest of the World Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

a.Middle East and Africa Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

b.Latin America Treatment Resistant Depression Market, Size and Forecast, 2015 to 2025

 

Prime Takeaways:

  1. Market size and forecast of the Treatment Resistant Depression market for the period 2015 to 2025
  2. Compounded annual growth rate (CAGR%) for the segments and regional markets through 2025
  3. Market Share Analysis combined with competitive assessment of key players
  4. PESTEL analysis, by Geography/ Segments
  5. Overview of the key market players, in terms of business description, financial status, product portfolio and news coverage

1. Preface

1.1. Report Scope and Description

1.2. Research Methodology

2. Executive Summary

2.1. Europe Treatment Resistant Depression Market Snapshot

2.2. Europe Treatment Resistant Depression Market, by Drug Type, 2015 (US$ Mn)

2.3. Europe Treatment Resistant Depression Market Share, by Region, 2014 (Value %)

3. Europe Treatment Resistant Depression Market Analysis

3.1. Europe Treatment Resistant Depression Market Overview

3.2. Regulatory Guidelines (EU)

3.3. Efficacy Assessment: Major Combinations

3.3.1. TCA/SSRI

3.3.2. Mirtazapine/SSRI

3.3.3. TCA/MAOI 

3.3.4. SSRI/Bupropion 

3.4. Market Dynamics

3.4.1. Market Drivers

3.4.2. Challenges

3.4.3. Opportunities

3.5. Attractive Investment Proposition, 2015

3.6. Competitive Analysis: Fractal Map Investigation of Key Manufactures in Treatment Resistant Depression Market

4. Europe Treatment Resistant Depression Market, By Drug Type, 2014–2024 (US$ Mn)

4.1. Overview

4.2. Tricyclic antidepressants (TCAs)

4.3. Selective Serotonin Reuptake Inhibitors (SSRIs)

4.4. Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

4.5. Monoamine Oxidase Inhibitors (MAOIs)

4.6. Serotonin Neurotransmitter (5-HT2)-receptor Antagonists

4.7. Novel Agents (eg., mirtazapine, bupropion)

5. Europe Treatment Resistant Depression Market, By Region, 2014-2024 (US$ Mn)

5.1. Introduction

5.2. EU 28

5.3. CIS

5.4. Rest of Europe

6. Profiles

6.1. AstraZeneca

6.1.1. Business Description

6.1.2. Financial Health and Budget Allocation

6.1.3. Product Positions/Portfolio

6.1.4. News Coverage

6.2. Bristol-Myers Squibb

6.3. Eli Lilly and Company

6.4. Forest Laboratories

6.5. GlaxoSmithKline

6.6. Pfizer

6.7. Schering Plough

6.8. Wyeth

6.9. Other Notable Players

NA

NA

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)